TIME COURSE OF CHANGES IN THE LEVEL OF C-TERMINAL TELOPEPTIDES DURING THERAPY IN PATIENTS WITH OSTEOARTHRITIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The level of C-terminal telopeptides arising from collagen type II degradation during 3-month therapy using chondroitin sulfate (Structum), its combination with glucosamine hydrochloride (Artra) and Zeel T was estimated in patients with osteoarthritis. Better values were observed in gonarthrosis, particularly when Artra was used at the early stages of the disease; worse values were seen in Stage III osteoarthritis and its duration > 10 years.

Full Text

Restricted Access

About the authors

O. Maiko

Orenburg State Medical University

Email: omajko@yandex.ru
Professor, MD

E. Savelova

Orenburg State Medical University

Candidate of Medical Sciences

References

  1. Алексеева Л.И., Чичасова Н.В., Мендель О.И. Рациональный выбор базисной терапии при остеоартрозе. Результаты открытого рандомизированного многоцентрового исследования препарата АРТРА® в России // РМЖ. -2005; 13 (24): 1637-41.
  2. Каратеев А.Е. Гастродуоденальная безопасность селективных ингибиторов циклооксигеназы-2: проверка практикой // Тер. арх. - 2005; 5: 69-72.
  3. Каратеев А.Е., Алексеева Л.И., Братыгина Е.А. Оценка частоты развития побочных эффектов при длительном применении нимесулида в реальной клинической практике // РМЖ. - 2009; 17 (21): 1466-72.
  4. Майко О.Ю. Клинико-экономические аспекты применения нестероидных противовоспалительных и модифицирующих структуру хряща средств при остеоартрозе. Автореф. дис.. д-ра мед. наук. Оренбург, 2008; 43 с.
  5. Насонова В.А., Алексеева Л.И., Архангельская Г.С. и др. Итоги многоцентрового клинического исследования препарата структум в России // Тер. арх. - 2001; 11: 84-7.
  6. Насонова В.А. Остеоартроз: проблема полиморбидности // Consilium Medicum. - 2009; 11 (2): 234-45.
  7. Штрессер В., Вайзер М. Гомеопатическое лечение гонартроза: результаты двойного слепого исследования // Биол. медицина. - 2001; 2: 21-6.
  8. Эрдес Ш.Ф., Фоломеева О.М. Ревматические заболевания и инвалидность взрослого населения Российской Федерации // Научно-практическая ревматол. - 2007; 4: 4-9.
  9. Christgan S., Henrotin Y., Tanko L. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate // Clin. Exp. Rheumatol. - 2004; 22 (1): 36-42.
  10. Ishijima M., Watari T., Naito K. et al. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis // Arthritis Research & Therapy. -2011; 13 (1): 2.
  11. Jung M. Elevated urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis // Pathobiology. - 2004; 71 (2): 70-6.
  12. Hochberg M. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration // Osteoarthritis Cartilage. - 2010; 18 (1): 28-31.
  13. Garnero P., Charni N., Juillet F. et al. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis // Ann. Rheum. Dis. - 2006; 65: 1639-44.
  14. Gineyts E., Mo J., Ko A. et. al. Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis // Ann. Rheum. Dis. - 2004; 63: 857-61.
  15. Kahan A., Uebelhart D. et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial // Arthr. Rheum. -2009; 60: 524-33.
  16. Manicourt D., Bevilacqua M., Righini V. et al. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis // Drugs R.D. - 2005; 6: 261-71.
  17. Mazzuca S., Brandt K., Eyre D. et al. Urinary levels of type II collagen c-telopeptide crosslinks are unrelated to joint space narrowing in patients with knee osteoarthritis // Ann. Rheum. Dis. - 2006; 65: 1055-9.
  18. Marrona U., Weiser M., Klein P. Orale Behandlung der Gonarthrose mit Zeel compositum // Orthop. Praxis. - 2000; 5: 285-91.
  19. Oestergaard S., Chouinard L., Doyle N. et al. Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis // Arthr. Rheum. - 2006; 54: 2886-90.
  20. Rozendaal R., Uitterlinden E. et al. Glucosamine sulphate effects on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial // Osteoarthritis Cartilage. - 2009; 17: 427-32.
  21. Reijman M., Hazes J., Bierma-Zeinstra S. A new marker for osteoarthritis: cross-sectional and longitudinal approach // Arthr. Rheum. - 2004; 50; 2471-8.
  22. Sharif M., Kirwan J., Charni N. et al. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis-association with disease progression // Rheumatology. - 2007; 46: 938-43.
  23. Zhang W., Nuki G., Moskowitz R. et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009 // Osteoarthritis Cartilage. - 2010; 18: 476-99.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies